Our Team

David Ribeiro

Dr David Ribeiro has extensive experience in commercialising products within chronic diseases, having previously held senior management roles at Solvay Healthcare, Encysive Pharmaceuticals and Pfizer. Most recently, David held the role of European Business Manager at Pharmaxis Pharmaceuticals Limited, a Sydney-based company with two launched products – a diagnostic test for assessing bronchial hyper-­responsiveness in asthma, and a therapeutic product designed for the chronic treatment of patients with Cystic Fibrosis.

David is a graduate of the University of Surrey, in Guildford, where he obtained a BSc in Biochemistry.  He continued his studies to gain an MSc in Clinical Biochemistry, and then completed a PhD, investigating the impact of shift work on cardiovascular risk factors.

David Ribeiro

Chief Executive Officer
David Ribeiro
Brian Walker

Brian Walker

Chief Scientific Officer
Professor Walker has over 30 years experience in the design & synthesis of “Protease-Tags” for the identification and validation of protease targets of biomedical and
Read More
Kelly Moffitt

Kelly Moffitt

Senior Project Manager
Dr Kelly Moffitt has extensive research experience in the role of host proteases involved in both inflammation and infection, particularly within various respiratory diseases including
Read More
Meryl Parker

Meryl Parker

Market Access Manager
Read More
Charlene Robb

Charlene Robb

Regulatory and R&D Scientist
Charlene obtained a MPharm degree from Queens University Belfast (QUB) in 2010 before completing pre-registration training and qualifying as a pharmacist in 2011. She returned
Read More
Darragh McCafferty

Darragh McCafferty

R&D Scientist
Darragh McCafferty graduated in 2004 with a Master of Pharmacy degree from Queen's University Belfast, and completed his pre-registration training in
Read More
Timothy Ferguson

Timothy Ferguson

R&D Scientist
Timothy graduated from Queen’s University Belfast with a Master of Pharmacy degree in 2011. Following successful completion of pre-registration training, he returned to the School
Read More